Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000239104 | SCV000297397 | uncertain significance | not specified | 2015-11-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082158 | SCV000653614 | benign | Cryptosporidiosis-chronic cholangitis-liver disease syndrome | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000531186 | SCV001150876 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | IL21R: BP4, BS1, BS2 |
ARUP Laboratories, |
RCV000531186 | SCV001157298 | likely benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002518530 | SCV003542325 | likely benign | Inborn genetic diseases | 2021-08-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomics, |
RCV003224239 | SCV003920064 | uncertain significance | IgE responsiveness, atopic; Cryptosporidiosis-chronic cholangitis-liver disease syndrome | 2021-03-30 | criteria provided, single submitter | clinical testing | IL21R NM_021798.3 exon 8 p.Arg275Gln (c.824G>A): This variant has not been reported in the literature but is present in 0.9% (1254/128760) of European alleles, including 9 homozygotes in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/16-27457366-G-A). This variant is present in ClinVar (Variation ID: 252799). This variant amino acid Glutamine (Gln) is present in >10 species and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |